![Additional proxy soliciting materials - form defa14a](https://www.moneycontroller.it/upload/aziende/4d-molecular-therapeutics-inc_20210726124021.jpg)
☐
|
Preliminary Proxy Statement
|
||||
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
||||
☐
|
Definitive Proxy Statement
|
||||
☒
|
Definitive Additional Materials
|
||||
☐
|
Soliciting Material Under §240.14a-12
|
Payment of Filing Fee (Check all boxes that apply):
|
|||
|
|
||
☒
|
|
|
No fee required.
|
☐
|
|
|
Fee paid previously with preliminary materials.
|
☐
|
|
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
Attachments
Disclaimer
4D Molecular Therapeutics Inc. published this content on 10 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 April 2024 20:11:49 UTC.